bluebird bio
Johanna Griecci currently serves as a Principal Associate Scientist at bluebird bio, focusing on CAR-T and immunotherapy initiatives since January 2014. Prior experience includes a role as a Research Associate at OvaScience, where responsibilities involved optimizing a mitochondria enrichment process for various egg precursor cells and developing a whole cell luminescent ELISA. Previous positions at Agenus and Percivia involved significant contributions to mitochondrial enrichment processes and the development of analytical assays for biosimilar proteins, respectively. With a strong background in molecular immunology and protein purification, Johanna Griecci has also made substantial impacts through the execution of various assays and collaborative projects throughout a career that began with an internship at Dyax Corp. Educational qualifications include a Bachelor of Science in Biology from Northeastern University and additional studies at Harvard University Extension School.
bluebird bio
40 followers
bluebird bio is developing innovative gene therapies for severe genetic diseases and cancer. Its vision is to make the hope of gene therapy a reality.